CliffBio
small molecule

TETRACAINE HYDROCHLORIDE

TETRACAINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameTETRACAINE HYDROCHLORIDE
Active ingredientTETRACAINE HYDROCHLORIDE
Strength0.5%
Dosage formSOLUTION
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalFebruary 2016
Marketing statusRX

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TETRACAINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio